BioSpace News Archive

Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at the Clinical Trials in Rare Diseases Conference on September 14th, 2021.

Athlos Oy received 510 acceptance on July 22nd, 2021 for DC-Air™, a new generation of intraoral X-ray imaging sensors that will pave the way for the future of X-ray imaging.

Dexcom, Inc., a leader in real-time continuous glucose monitoring, is pleased to announce the Dexcom G6 CGM System is now covered by the Non-Insured Health Benefits Program for people living with diabetes who are between 2 and 19 years old and require intensive insulin therapy.

AVITA Medical, Inc. announced today that its management will present at the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. Eastern Daylight Time

Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Benitec Biopharma, Inc. today announced that Jerel A. Banks , M.D., Ph.D., Executive Chairman and Chief Executive Officer will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

Eliem Therapeutics, Inc. today reported financial results and business highlights for the quarter ended June 30, 2021.

IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment

Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common stock at $31.00 per share.